ANTIBACTERIAL AND ANTIFUNGAL AGENTS Flashcards
DNA localisation
Bacteria are ‘prokaryotes’ ie their DNA exists as a ring-like structure in the cytoplasm
Fungi are ‘eukaryotes’ ie their DNA is separated from the cytoplasm by a nuclear membrane
Size
Bacterial cells are much smaller than fungal cells
Structure
Bacterial cells are uniform simple structures
Fungal cells may have a complex structure and the same organism may have many different forms (hyphae, spores etc)
Cellular processes
Fungal protein and DNA synthesis very similar to human processes
Antibiotics
Chemical products of microbes that inhibit or kill other organisms
Antimicrobial agents (antibacterial, antifungal, antiviral);
Antibiotics, Synthetic compounds with similar effect
Semi-synthetic i.e. modified from antibiotics: Different antimicrobial activity/spectrum, pharmacological properties or toxicity. Terms antibiotic and antibacterial agent are often used interchangeably
Bacteriostatic/ fungistatic
Inhibit growth e.g. protein synthesis inhibitors
Bacteriocidal/ fungicidal
Kill E.g. cell wall-active agents
Minimum Inhibitory Concentration
MIC Minimum conc. of antimicrobial agent at which visible growth is inhibited
Minimum bactericidal/fungicidal concentration
MBC/MFC: Minimum concentration of antimicrobial agent at which most organisms are killed.
Synergism
Activity of two antimicrobials given together is greater than the sum of their activity if given separately
Antagonism
One agent diminishes the activity of another
Indifference
Activity unaffected by the addition of another agent
Bacterial cell wall
Peptidoglycan:
Major component of bacterial cell wall
Both Gram-positive and Gram-negative
Polymer of glucose-derivatives, N-acetyl muramic acid (NAM) and N-acetyl glucosamine (NAG)
No cell wall in animal cells so Ideal potential for selective toxicity
Cell wall synthesis inhibitors
• Antibacterial agents (classes)
– β-lactams
– Glycopeptides
Fungal cell wall
β-1,3-glucan:
Large polymer of UDP-glucose
50 60% of the dry weight of the fungal cell wall
Form a fibrous network on the inner surface of the cell wall. Synthesized by β-1,3-glucan synthase
No cell wall in animal cells so Ideal potential for selective toxicity
Cell wall synthesis inhibitors
• Antifungal agents
– Echinocandins
Beta-lactams (antibacterial: huge class of antibiotic)
First true antibiotics in clinical practice = Benzylpenicillin. All contain β-lactam ring. Four-membered ring structure (C-C-C-N). Structural analogue of D-alanyl-D-alanine. Interfere with function of ‘penicillin binding proteins’ which are trans-peptidases enzymes involved in the peptidoglycan cross-linking.
PENICILLINS
Benzylpenicillin, phenoxymethylpenicillin, flucloxacillin relatively narrow spectrum
Broad spectrum penicillin’s: amoxicillin (now narrower) and pivmecillinam. Penicillinase-resistant penicillin: flucloxacillin. IF SOMETHING ENDS IN CILLIN: IT IS A BETA LACTAM.
CEPHALOSPORIN’S:
cephalexin, cefuroxime, cefotaxime, ceftriaxone, ceftazidime broad spectrum and arranged into generations.
CARBAPENEMS
Ertapenem, imipenem, meropenem Extremely broad spectrum
MONOBACTAM
Aztreonam gram negative activity only. Has only one ring so not got same allergic implications
-lactamase enzymes
are enzymes that hydrolyse (inactivate) β-lactams. It is a common mechanism of resistance to β-lactam antibiotics. Different β-lactamase enzymes confer resistance to a narrow or wide range of β-lactams eg:
– Staphylococcal β-lactamase – some penicillins only
– ‘Extended spectrum β-lactamase’ (ESBL) – penicillins and cephalosporins
– Carbapenemases (eg NDM1) – carbapenems
β-lactam/β-lactamase inhibitor combinations (BLBLI)
• Amocixillin-clavulanate (Augmentin): Increases the spectrum of amoxicillin
• Piperacillin-tazobactam (Tazocin: Increases the spectrum of piperacillin
• ESBL and carbapenemase BLBLIs: Work in progress
Problems with BLBLIs: Very broad spectrum, so predispose to C. difficile infection. Names do not end with –illin or start with cef-. Importance of penicillin allergy may be missed